Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Dronabinol + palmidrol by Evero Health for Tourette Syndrome: Likelihood of Approval
Dronabinol + palmidrol is under clinical development by Evero Health and currently in Phase II for Tourette Syndrome. According to...